Blood-Test Services Compared: Price per Biomarker, Labs and the Companies Behind Them

Where to buy your own blood work, scored on one 100-point rubric: price per biomarker, breadth, retest cost, clinician review and lab, plus the company behind it. Eight services scored, five picks, and every number sourced.

By Kymata Health Editorial Last checked For everyone

Key takeaways

4 points
  • Top five: Function Health 96, Superpower 87, Mito Health 80, Ulta Lab Tests 75 and Everlywell 71, out of 100. See the picks.
  • The annual bundles are cheapest per marker if you test twice a year: Function is about $30 a month ($365 a year) for 160+ tests and Superpower about $29 a month ($349 a year) for 150+ biomarkers, both at Quest12.
  • Pay-per-test services suit one broad panel a year or a few markers: Mito’s 166-biomarker Pro Panel is $323.88 for members at Quest, Ulta’s 117-biomarker panel $449.9534.
  • Company checks matter: we score founders, funding, years selling, privacy and lawsuits. How we score.

Guides in this hub

5 guides
  1. The 5 Best Blood-Test Services for Value and Trust, Scored on One RubricEight companies that sell broad blood panels direct to you, scored out of 100 on price per biomarker, breadth, retest cost, clinician review and lab, and on who runs the company: founders, funding, years selling, privacy and legal record. Mito Health, our affiliate partner, is scored on the same rubric.
  2. How We Score Blood-Test Services: The 100-Point RubricThe published rubric behind our blood-test rankings: 60 points for value and lab quality, 40 for the company behind the test. Medals need 80 or more, and payment never changes a score.
  3. Who Runs the Blood-Test Companies: Founders, Funding, Privacy and LawsuitsThe company checks behind our blood-test rankings: who founded each service, what backs it, how long it has sold tests, how it handles health data, and any lawsuits or breaches we found.
  4. Choosing an At-Home NAD+ or Longevity Test: What to Check Before You PayAt-home NAD+ and biological-age tests are easy to order and hard to interpret. Before you buy one, check what sample it uses, which lab runs it, whether you can repeat it the same way, and what you would actually do with the result.
  5. Pharmacogenomic (PGx) Testing: What a DNA Medication-Response Test Shows, What the FDA Says, and Its LimitsA pharmacogenomic test reads genes that change how your body handles certain drugs. For a short list of gene-drug pairs the evidence is strong enough to change a prescription. For most medicines it is not, and the FDA has warned against tests that claim otherwise.

Researched and written by Kymata Health Editorial; sources cited inline. Drawn from the studies and documents cited below. Educational only, not medical advice.

Start here

Three guides: the ranked picks with prices, the full rubric, and the company checks behind the scores. For a single test before you supplement, see where to order your own blood work.

A result is a number, not a diagnosis. Take anything out of range to a clinician who knows your history.

How we make money and how this was checked

How we make money: Mito Health, Everlywell and HealthLabs.com are affiliate partners, so Kymata Health may earn a commission if you buy through their links on this page, at no extra cost to you; the owner of Kymata Health also pays for a Mito membership. We have no affiliate relationship with Function Health, Superpower, Ulta Lab Tests, Quest Health or InsideTracker. Payment never changes a score: every service is scored on the same published rubric.

How this was checked: researched and written by our editorial team from each company’s own pages, court records and press coverage, read on Oct 13, 2026. It is not medical advice.

Find the evidence

Ask our graded human trials about a goal, a grade, a trial size, two supplements or a medicine. Answers are assembled on your device from the rows.

Evidence finder

3,342 trial rows · 869 interaction rows

Vitamin D3 vs D2: 15 graded trial rows. Best grade among rows showing a benefit: B.

Verdicts: 3 improved, 9 found no effect, 2 mixed, 1 worsened.

Grades of the 15 rows: B 1C 5No effect 9

Matching trial rows, strongest grade first

  1. Vitamin D3 vs D2Grade B

    Raising blood 25(OH)D: D3 vs D2

    Improved · 95 people · RCT · 2013

  2. Vitamin D3 vs D2Grade C

    Cancer death

    Mixed · 104,727 people · Meta‑analysis · 2023

  3. Vitamin D3 vs D2Grade C

    Acute respiratory infections

    Improved · 48,488 people · Meta‑analysis · 2021

Assembled from 15 graded trial rows when this page was built.

Fixed sentence templates filled from our rows; every line links to its row. Not medical advice.

Where to buy

Clinics and services

  • Mito Health: Pay-per-test lab marketplace: members ($9/mo or $99/yr) pay Mito’s cost on 1,000+ tests at Quest, Labcorp or BioReference, with clinician review. Scored 80/100 on our rubric.

    See Mito test prices (paid link, opens in new tab)

  • Everlywell: Everlywell 360: about $33 a month (billed $399 a year) for one 83-biomarker test a year at Quest with a clinician-reviewed care plan. Scored 71/100. We do not recommend its IgG food sensitivity test.

    See Everlywell's lab tests (paid link, opens in new tab)

  • HealthLabs.com: Pay per test with no membership: its doctors issue the lab order and you walk in at a partner lab such as Quest or Labcorp. Single tests start low (total testosterone $49, A1c $29 on Oct 14, 2026), but its broadest wellness panel is $939, so it scored 57/100 on our rubric. Not available in NY, NJ, RI, MD, ND or HI.

    See HealthLabs test prices (paid link, opens in new tab)

Regulatory and legal notes

  • Function Health sued Superpower in January 2026 under the Lanham Act, alleging its biomarker counts and comparison ads were misleading; the court dismissed the case on June 12, 2026 after the parties settled, without ruling on the claims5.
  • Everlywell faces class actions alleging its IgG food sensitivity test cannot identify food sensitivities (Spiro, C.D. Cal.; Toth, 1st Cir. arbitration appeal 2024)67.
  • In 2019 a breach at AMCA, a billing-collections vendor, exposed personal and financial data (not lab results) of about 11.9 million Quest Diagnostics patients8.

Other names you will see

Listed for completeness. We have no paid relationship with these brands and do not link to them.

  • SiPhox Health: Its own pricing page listed panels but no price on Oct 13, 2026, so we could not score value; at-home collection, CLIA- and CAP-accredited lab; founded by MIT researchers.
  • Lifeforce: A membership that pairs blood panels with clinician-guided plans, co-founded by CEO Dugal Bain-Kim with Tony Robbins and Peter Diamandis ($12M Series A, 2023); we could not confirm a current price, so it is not scored.
  • Marek Health: Its co-founder is identified only as 'Derek' (More Plates More Dates) on its own site, and we found no funding or ownership disclosure, so it is not scored.
  • Jinfiniti: Specialty aging and NAD+ panels run in its own CLIA-certified lab, founded by Jin-Xiong She, PhD; not a broad routine panel, so price per marker is not comparable.
  • Rythm Health: We could not verify its founders' backgrounds or a current price from the company's own pages.

References

Every study and document cited on this page, numbered as in the text.

Sources

8 sources
  1. 1Function Health pricing: about $30 a month ($365 yearly membership), 160+ lab tests a year, clinician review. Function Health, 2026.
  2. 2Superpower membership: about $29 a month ($349 a year), 150+ biomarkers across 2 blood draws. Superpower, 2026.
  3. 3Mito Pro Panel: biomarkers, member and non-member price by lab. Mito Health, 2026.
  4. 4Ulta Lab Tests home page: Baseline Biomarkers panels and prices. Ulta Lab Tests, 2026.
  5. 5Function Health, Inc. v. Superpower Health Inc., No. 2:26-cv-00810 (C.D. Cal.): docket and June 12, 2026 order of dismissal after settlement. Justia Dockets, 2026.
  6. 6Spiro v. Everly Well, Inc. class action complaint (C.D. Cal.): IgG food sensitivity test. Truth in Advertising (court filing), 2023.
  7. 7Toth v. Everly Well, Inc., No. 23-1727 (1st Cir. 2024): IgG food sensitivity test class action, arbitration appeal. U.S. Court of Appeals for the First Circuit, 2024.
  8. 8Quest Diagnostics statement on the AMCA data security incident (about 11.9 million patients). Quest Diagnostics, 2019.

Dietary supplements are not intended to diagnose, treat, cure or prevent any disease, and these statements have not been evaluated by the FDA. Prescription options need a licensed clinician. Talk to your clinician or pharmacist before starting anything new, especially if you take prescription medicines, are pregnant or breastfeeding.

Educational only. Not medical advice. Some links earn us a commission: kymatahealth.com/affiliate-disclosure.